Related Experiment Video
Updated: Jul 20, 2025
04:11
Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
Published on: December 15, 2023
3.5K
Hepatitis C Elimination: Opportunities and Challenges in 2023
Gadeer Taha1, Levy Ezra2, Naim Abu-Freha3,4
1Department of Gastroenterology, Rambam Health Care Campus, Haifa 31096, Israel.
Viruses
|July 29, 2023
Summary
Hepatitis C Virus (HCV) elimination requires accessible pan-genotypic therapies. Overcoming barriers in screening, testing, and treatment delivery is crucial for national HCV eradication efforts.
Area of Science:
- Hepatology
- Infectious Diseases
- Public Health
Background:
- Hepatitis C Virus (HCV) infection is a primary cause of liver cirrhosis and related mortality.
- HCV necessitates liver transplantation and poses a significant global health burden.
- Recent advancements offer effective, pan-genotypic treatments for HCV.
Purpose of the Study:
- To outline challenges and interventions for Hepatitis C Virus elimination.
- To identify barriers in screening, diagnosis, and treatment accessibility.
- To propose strategies for improving HCV management and patient outcomes.
Main Methods:
- Review of current HCV treatment landscape and elimination initiatives.
- Analysis of systemic and individual-level barriers to care.
- Identification of potential interventions for enhanced HCV management.
Main Results:
- Effective pan-genotypic therapies exist, but accessibility remains a challenge.
- Barriers include inadequate screening, laboratory infrastructure, and treatment access.
- Decentralization of services, increased funding, and awareness campaigns are recommended.
Conclusions:
- Achieving Hepatitis C Virus elimination requires addressing multifaceted barriers.
- Interventions must focus on improving screening, diagnostics, and treatment delivery.
- Special attention to at-risk populations and leveraging technology like telemedicine is vital.
More Related Videos
Related Concept Videos
01:16Hepatic Drug Excretion: Influencing Factors
155
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
155
01:23Drug Elimination: Non-Renal Routes
2.4K
The liver plays a pivotal role in eliminating drugs and their metabolites, primarily through a process known as biliary excretion. This process involves the hepatocytes, the primary cells in the liver that generate bile. A range of transporters actively expels polar drugs or hydrophilic drug metabolites into the bile, which transports the drugs and metabolites into the small intestine. From here, they are eventually expelled from the body through feces. In some instances, the original drug or a...
2.4K
01:17Hepatic Drug Excretion: Enterohepatic Cycling
1.6K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
1.6K
01:09Hepatic Drug Clearance: Restrictive and Nonrestrictive Clearance
144
Hepatic clearance refers to the volume of blood cleared of a drug by the liver per unit of time. It plays a crucial role in drug metabolism and elimination. While hepatic clearance is commonly estimated by subtracting renal clearance from total body clearance, other pathways, such as pulmonary or biliary clearance, may also contribute. However, these pathways are generally less significant than hepatic and renal clearance.
Most drugs undergo restrictive clearance, which is proportional to the...
Most drugs undergo restrictive clearance, which is proportional to the...
144
01:14Hepatic Drug Clearance: Role of Transporters
86
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
86
01:06Drug Elimination: The Concept of Clearance
2.7K
Drug elimination refers to removing drugs from the body, either through urine by the kidneys or through bile by the liver. Drug clearance is a pharmacokinetic parameter that measures the efficiency of drug removal from the bloodstream within a specific time frame. It is calculated as the rate at which a drug is eliminated from plasma divided by the plasma concentration of the drug.
Drug clearance is not limited to renal excretion but encompasses all organs involved in drug elimination,...
Drug clearance is not limited to renal excretion but encompasses all organs involved in drug elimination,...
2.7K